Monica Hrynchak

New Westminster, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A De Novo Algorithm for Allele Reconstruction from Oxford Nanopore Amplicon Reads, with Application to CYP2D6.

A De Novo Algorithm for Allele Reconstruction from Oxford Nanopore Amplicon Reads, with Application to CYP2D6.

Journal: Bioinformatics (Oxford, England)

Published: November 13, 2025

A 1p31.3 deletion encompassing the nuclear factor 1A gene presenting as possible temporal lobe epilepsy in association with schizoaffective disorder.

A 1p31.3 deletion encompassing the nuclear factor 1A gene presenting as possible temporal lobe epilepsy in association with schizoaffective disorder.

Journal: Neurocase

Published: October 09, 2022

Aggressive B-cell lymphoma with t(3;8)(q27;q24) in an elderly patient.

Aggressive B-cell lymphoma with t(3;8)(q27;q24) in an elderly patient.

Journal: American journal of hematology

Published: November 18, 2021

Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada.

Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada.

Journal: Leukemia research

Published: October 02, 2020

Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.

Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.

Journal: Leukemia research

Published: December 12, 2019

Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient.

Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient.

Journal: Blood

Published: January 26, 2019

Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.

Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.

Journal: Clinical lymphoma, myeloma & leukemia

Published: February 28, 2017

Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada.

Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada.

Journal: Leukemia research

Published: October 31, 2016

Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada.

Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada.

Journal: Cancer genetics

Published: May 11, 2016

A novel microdeletion affecting the CETP gene raises HDL-associated cholesterol levels.

A novel microdeletion affecting the CETP gene raises HDL-associated cholesterol levels.

Journal: Clinical genetics

Published: March 14, 2015

Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.

Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.

Journal: Genes, chromosomes & cancer

Published: February 10, 2015

Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.

Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.

Journal: Cancer genetics

Published: February 15, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026